| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.79 | 0.002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.35 | 7e-10 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.27 | 0.08 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.22 | 5e-06 |